← Back to Search

Lactate Sensor

Pilot Testing a Novel Non-invasive Lactate Sensor

N/A
Waitlist Available
Led By Peter E Light, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new device called Lactisense that measures lactate levels through the skin without drawing blood. It targets people doing strenuous leg exercises because their lactate levels rise during such activities. The device uses microwaves to detect these changes and sends the data to a nearby reader.

Eligible Conditions
  • Hyperlactatemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
That the lactate sensor under test is able track increase in interstitial lactate levels in exercising humans that follow the same time course as lactate values obtained from a commercial blood capillary lactate monitor.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Evaluation of non-invasive lactate sensorExperimental Treatment1 Intervention
To determine the efficacy and accuracy of the non-invasive lactate sensor
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lactate sensor (Lactisense)
2022
N/A
~10

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
942 Previous Clinical Trials
434,400 Total Patients Enrolled
Peter E Light, PhDPrincipal InvestigatorUniversity of Alberta

Media Library

Lactisense (Lactate Sensor) Clinical Trial Eligibility Overview. Trial Name: NCT05649358 — N/A
Hyperlactatemia Research Study Groups: Evaluation of non-invasive lactate sensor
Hyperlactatemia Clinical Trial 2023: Lactisense Highlights & Side Effects. Trial Name: NCT05649358 — N/A
Lactisense (Lactate Sensor) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05649358 — N/A
~3 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top